IFC Bolsters Support for Better Healthcare in Colombia with Investment in Procaps
Procaps is a leading manufacturer of high-quality medicines with activities ranging from product development to pharmaceutical production and distribution in several countries throughout
Softgel capsules are an advanced delivery system that allows for wider formulations, precise dosage, and stability of formulations. In addition, since softgel capsules require specialized manufacturing technologies, they cannot be easily counterfeited.
IFC funding will help the company increase access to quality affordable products through increasing production capacity and efficiency of its manufacturing plants, acquiring new brands and increasing the Group's M&A headroom.
“We are extremely pleased to have IFC as a partner in Procaps,” said
IFC's investment seeks to improve access to quality affordable pharmaceutical products, which remains a challenge across
“This support for a leading pharmaceutical company such as Procaps will improve access to high quality affordable medicine and demonstrates IFC's capacity to invest in and partner with private companies that are driving the economic development of
The investment fits within IFC's broader strategy of improving the supply of high-quality medical products in developing countries by helping manufacturers and distributors grow and enter new markets. IFC is the world's largest multilateral investor in private healthcare, managing an active portfolio of about
SOURCE
The London links between high finance and the high seas
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Health Insurance Innovations, Inc. and Encourages Investors with Losses to Contact the Firm
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News